Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 364.75M | 345.63M | 260.47M | 213.12M | 224.88M | 234.99M |
Gross Profit | 11.25M | 11.99M | 21.69M | 3.09M | 9.15M | 8.91M |
EBITDA | -12.72M | -9.25M | 4.69M | -10.74M | 5.17M | -2.05M |
Net Income | -17.61M | -14.54M | 1.19M | -13.56M | 2.56M | -4.95M |
Balance Sheet | ||||||
Total Assets | 142.78M | 168.65M | 144.38M | 125.42M | 125.17M | 131.61M |
Cash, Cash Equivalents and Short-Term Investments | 20.63M | 23.27M | 26.33M | 10.45M | 47.05M | 31.53M |
Total Debt | 26.08M | 38.19M | 16.63M | 14.95M | 2.31M | 1.39M |
Total Liabilities | 79.82M | 100.30M | 61.53M | 54.53M | 37.20M | 43.80M |
Stockholders Equity | 61.87M | 68.18M | 82.72M | 70.89M | 87.97M | 87.82M |
Cash Flow | ||||||
Free Cash Flow | 9.10M | -29.18M | -7.01M | -40.67M | 19.19M | 20.66M |
Operating Cash Flow | 11.29M | -27.46M | -6.87M | -39.27M | 19.24M | 21.03M |
Investing Cash Flow | 176.00K | 4.65M | 105.00K | -1.28M | 1.04M | -5.06M |
Financing Cash Flow | -15.83M | 19.76M | 22.65M | 3.95M | -4.76M | -6.16M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | HK$43.00M | 4.57 | 9.85% | ― | -7.08% | -23.53% | |
58 Neutral | HK$13.89B | 4.25 | -3.01% | 7.32% | 3.67% | -54.16% | |
53 Neutral | HK$179.08M | 16.40 | 4.17% | ― | 2.61% | 8.70% | |
53 Neutral | HK$179.08M | 16.40 | 4.17% | ― | 2.61% | 8.70% | |
47 Neutral | HK$1.53B | ― | -30.10% | ― | 130.71% | 51.92% | |
45 Neutral | HK$126.27M | ― | -26.83% | ― | -81.56% | 26.00% | |
38 Underperform | HK$98.60M | ― | -48.06% | ― | 18.07% | -492.42% | |
25 Underperform | HK$139.41M | ― | ― | -11.42% | 26.75% |